DMAAR Drugs Made In America Acquisition Corp. - Rights
$0.13
Price · May 20, 2026
Fundamentals as of May 14, 2026
DMAAR Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.13
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$0 – $0
DMAAR Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
DMAAR
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
DMAAR
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
DMAAR
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
DMAAR
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
DMAAR
Peer Median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 6
| Metric | Trend | Q1 2026 |
|---|---|---|
| SG&A Expense | $143.3K | |
| Operating Income | $-143.3K | |
| Interest Income | $2M | |
| Other Non-op | $2M | |
| Net Income | $2M | |
| EBITDA | $-143.3K |
Balance Sheet 13
| Metric | Trend | Q1 2026 |
|---|---|---|
| Cash & Equivalents | $14.9K | |
| Current Assets | $14.9K | |
| Total Assets | $242M | |
| Accounts Payable | $238.2K | |
| Short-term Debt | $100.0K | |
| Current Liabilities | $492.2K | |
| Total Liabilities | $7M | |
| Total Debt | $100.0K | |
| Common Stock | $1.1K | |
| Retained Earnings | $-7M | |
| Stockholders' Equity | $-7M | |
| Liabilities + Equity | $242M | |
| Shares Outstanding | 10,717,143 |
Cash Flow 2
| Metric | Trend | Q1 2026 |
|---|---|---|
| Operating Cash Flow | $-91.2K | |
| Financing Cash Flow | $100.0K |
Profitability 2
| Metric | Trend | Q1 2026 |
|---|---|---|
| ROA | 0.83% | |
| ROE | -27.1% |
Liquidity & Solvency 3
| Metric | Trend | Q1 2026 |
|---|---|---|
| Current Ratio | 0.0 | |
| Quick Ratio | 0.0 | |
| Debt / Equity | -0.0 |
Valuation (TTM) 6
| Metric | Trend | Q1 2026 |
|---|---|---|
| Net Income TTM | $8M | |
| Market Cap | $659.1K | |
| Enterprise Value | $744.2K | |
| P/B | -0.1 | |
| P / Cash Flow | -7.2 | |
| EV / EBITDA | -5.2 |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.